6
total announcements
KREBSBIO.NS · 15 min delayed
Krebs Biochemicals and Industries Limited
Krebs Biochemicals and Industries Limited has informed the Exchange about Copy of Newspaper Publication, which includes unaudited financial results for the 1st quarter ended June 30, 2026, and a notice regarding lost, destroyed, misplaced, or stolen share certificates.
Krebs Biochemicals and Industries Limited
Krebs Biochemicals and Industries Limited has submitted its unaudited financial results for the 1st quarter ended June 30, 2026, to the Exchange, following a board meeting.
Krebs Biochemicals and Industries Limited
Krebs Biochemicals and Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.
Krebs Biochemicals and Industries Limited
Krebs Biochemicals and Industries Limited has informed the Exchange about Scheme of Arrangement with Ipca Laboratories Limited, where the former will be amalgamated into the latter. The amalgamation is subject to necessary approvals and will result in operational synergies, cost optimization, and increased business for the combined entity.
Krebs Biochemicals and Industries Limited
Krebs Biochemicals and Industries Limited has approved a Scheme of Amalgamation with Ipca Laboratories Limited, subject to necessary approvals. The appointed date for the Scheme is 1st April, 2026, and the effective date will be upon receipt of all consents and approvals. The amalgamation will result in operational synergies, cost optimization, and an increased business for the combined entity.
Krebs Biochemicals and Industries Limited
Krebs Biochemicals and Industries Limited has announced the closure of its trading window for promoters, directors, designated persons, their immediate relatives, and connected persons. This closure is effective from the close of business hours on June 30, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the first quarter ended June 30, 2026. This measure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent insider trading ahead of the financial results.